The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12625000912482
Ethics application status
Approved
Date submitted
30/07/2025
Date registered
22/08/2025
Date last updated
22/08/2025
Date data sharing statement initially provided
22/08/2025
Type of registration
Prospectively registered

Titles & IDs
Public title
Digital-based supportive supervision for newborn care providers
Scientific title
Use of mobile phones for supportive supervision to manage quality of newborn care among healthcare providers in Lao People's Democratic Republic (PDR): A parallel cluster randomised controlled trial
Secondary ID [1] 315031 0
nil known
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Newborn care 338372 0
Neonatal adverse health outcomes 338373 0
breast feeding 338374 0
Condition category
Condition code
Public Health 334674 334674 0 0
Health service research
Reproductive Health and Childbirth 334675 334675 0 0
Childbirth and postnatal care

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
The intervention will be applied at cluster (district hospital) level. The intervention includes repeated self-practice by providers augmented with mobile phone-based supportive supervision by facilitators. Self-practice will be repeated once per month for both management of breathing and non-breathing babies.
Both intervention and control arms will receive an initial refresher Early Essential Newborn Care (EENC) coaching session at each of the district hospitals. The refresher coaching session will be provided by provincial facilitators. It is a one-day session that includes inductive lectures, hands-on practice and knowledge and skill assessments on management of breathing and non-breathing babies. Standardised assessments of provider knowledge and skills will be conducted before and after the coaching sessions.

Intervention arm: The intervention group will receive:
·After the initial one-day coaching, we will conduct a one-day workshop involving providers and representatives of the Board of Directors from that district hospital. Providers will practice taking and sending videos via a new WhatsApp group using their mobile phones. A data management system that is now under development may be attached to WhatsApp to manage the data exchanged between providers and facilitators. A protocol for the data management system development is separately developed and submitted to ethics committees. We will also discuss and agree on strategies for continuing the intervention by reviewing facilitators and barriers using the pCAT (pragmatic context assessment tool) checklist. We will then assign at least one person to monitor the implementation status at each district hospital.
·Providers in the intervention arm will conduct bi-weekly simulation-based self-practising on essential newborn care (once in a month each for management of breathing and non-breathing baby) alongside their clinical duties. They will also be encouraged to send videos of their performance during practice sessions to provincial facilitators bi-weekly, using the Social Network Service (SNS).
·We expect at least two videos per provider per month period will be sent to provincial facilitators.
·Provincial facilitators will review the videos and send feedback on how to handle newborns based on the EENC guidelines via the group SNS.
·As central facilitators are also members of this group, they can also provide individual feedback to the provincial facilitators regarding the comments they provided to district staff. We anticipate this will help provincial facilitators to improve their supervisory and feedback skills.
·The self-practise supported by the mobile phone-based supervision will continue for 12 months.
Intervention code [1] 331629 0
Behaviour
Comparator / control treatment
Control arm: Hospitals in the control arm will follow current standard practice (no follow-up educational interventions for providers). During the initial coaching, healthcare providers will be encouraged to continue their own daily practice, but there is no additional support after the initial coaching visit.
Control group
Active

Outcomes
Primary outcome [1] 342348 0
EENC skills among district healthcare providers at 12 months post coaching (Skill score)
Timepoint [1] 342348 0
1) Immediately before the refresher EENC coaching 2) Immediately after the refresher EENC coaching (baseline) 3) Three months after the baseline, 4) Six months after the baseline, 5) Nine months after the baseline, and 6) 12 months after the baseline (endline, primary timepoint)
Secondary outcome [1] 450411 0
Exclusive breastfeeding rate at 7 days of birth
Timepoint [1] 450411 0
7 days after birth.
Secondary outcome [2] 450412 0
Composite of neonatal adverse outcomes within 7 days of birth, defined as the occurrence of one or more of the following conditions: #1 Neonatal death within 7 days of birth regardless of location OR #2 Readmission to hospital between time of discharge and 7 days of birth OR #3 Neonatal transfer to other hospitals before discharge from a hospital of birth or within 7 days of birth for newborns staying hospital OR #4 Apgar score < 7 at 5 minutes OR #5 Bag and mask ventilation before discharge from a hospital of birth or within 7 days of birth for newborns staying hospital OR #6 Oxygen use for more than 2 hours before discharge from a hospital of birth or within 7 days of birth for newborns staying hospital #7 CPAP use for more than 2 hours before discharge from a hospital of birth or within 7 days of birth for newborns staying hospital #8 Seizure before discharge from a hospital of birth or within 7 days of birth for newborns staying hospital
Timepoint [2] 450412 0
7 days after birth.
Secondary outcome [3] 450413 0
Success rate of chest rise within 1 minute
Timepoint [3] 450413 0
1) Immediately before the refresher EENC coaching 2) Immediately after the refresher EENC coaching (baseline) 3) 12 months after the baseline (endline),
Secondary outcome [4] 450414 0
EENC knowledge among district healthcare providers at 12 months post coaching (knowledge score).
Timepoint [4] 450414 0
1) Immediately before the refresher EENC coaching 2) Immediately after the refresher EENC coaching (baseline) 3) 12 months after the baseline (endline),
Secondary outcome [5] 450415 0
Fidelity of implementing the intervention
Timepoint [5] 450415 0
12 months after the baseline
Secondary outcome [6] 450730 0
Factors influencing the implementation of the intervention.
Timepoint [6] 450730 0
12 months after the baseline
Secondary outcome [7] 450731 0
The mechanism of impact
Timepoint [7] 450731 0
12 months after the baseline

Eligibility
Key inclusion criteria
District-level healthcare providers providing newborn care in district hospitals will be recruited into the trial.
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
Yes
Key exclusion criteria
No exclusion criteria

Study design
Purpose of the study
Educational / counselling / training
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
The random number will be generated by a study statistician and will be concealed from the data collectors and EENC facilitators until they visit district hospitals to introduce the intervention.
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
The random number will be generated by a study statistician and will be concealed from the data collectors and EENC facilitators until they visit district hospitals to introduce the intervention.
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Parallel
Other design features
Phase
Not Applicable
Type of endpoint/s
Efficacy
Statistical methods / analysis
All analyses will be done by intention-to-treat, which means that clusters will be analysed according to their randomised allocation. Healthcare providers baseline characteristics such as age, sex, position, experience in years will be summarised as means and standard deviations, medians and inter-quartile ranges, or numbers and percentages, as appropriate, grouped by trial arm. A trial diagram will be presented showing the outcome by cluster. To ensure that cluster randomisation is successful, the significance of differences between the intervention and control groups for the baseline characteristics of participants will be examined using chi-squared test and t-test.
Primary outcome (Skills score)
We will compare the average score of the skills score between the intervention and control groups using a linear mixed-effects model employing the maximum likelihood method adjusted for its baseline skill score. To deal with missing data, we will conduct 1) alternative mixed methods without imputation, 2) single imputation, using the last observation carried forward, and 3) multiple imputation using predictive mean matching. In the alternative mixed methods, interaction between the intervention and time (baseline and endline) will be estimated. Assumption of missing at random will be examined before applying imputations. In the multiple imputations, we will conducted 20 imputations by including the corresponding baseline value of the primary outcome and the intervention value. Sensitivity analyses will be planned to use the per protocol set (PPS). We will also perform analysis adjusted for all baseline variables.

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment outside Australia
Country [1] 27258 0
Lao People's Democratic Republic
State/province [1] 27258 0

Funding & Sponsors
Funding source category [1] 319595 0
Government body
Name [1] 319595 0
Japan Society for the Promotion of Science
Country [1] 319595 0
Japan
Primary sponsor type
Other
Name
Burnet Institute
Address
Country
Australia
Secondary sponsor category [1] 322098 0
University
Name [1] 322098 0
University of Yamanashi
Address [1] 322098 0
Country [1] 322098 0
Japan
Other collaborator category [1] 283605 0
Government body
Name [1] 283605 0
Ministry of Health
Address [1] 283605 0
Country [1] 283605 0
Lao People's Democratic Republic
Other collaborator category [2] 283606 0
Government body
Name [2] 283606 0
Lao Tropical Public Health Institute
Address [2] 283606 0
Country [2] 283606 0
Lao People's Democratic Republic
Other collaborator category [3] 283607 0
University
Name [3] 283607 0
Juntendo University
Address [3] 283607 0
Country [3] 283607 0
Japan

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 318159 0
Alfred Hospital Ethics Committee
Ethics committee address [1] 318159 0
Ethics committee country [1] 318159 0
Australia
Date submitted for ethics approval [1] 318159 0
15/04/2025
Approval date [1] 318159 0
03/06/2025
Ethics approval number [1] 318159 0
286/25
Ethics committee name [2] 318161 0
National Ethics Committee for Health Research of the Lao People's Democratic Republic
Ethics committee address [2] 318161 0
Ethics committee country [2] 318161 0
Lao People's Democratic Republic
Date submitted for ethics approval [2] 318161 0
07/04/2025
Approval date [2] 318161 0
22/05/2025
Ethics approval number [2] 318161 0
2025.26

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 143302 0
Dr Sayaka Horiuchi
Address 143302 0
Burnet Institute 85 Commercial Rd, Melbourne VIC 3004
Country 143302 0
Australia
Phone 143302 0
+61421829124
Fax 143302 0
Email 143302 0
Contact person for public queries
Name 143303 0
Sayaka Horiuchi
Address 143303 0
Burnet Institute 85 Commercial Rd, Melbourne VIC 3004
Country 143303 0
Australia
Phone 143303 0
+61421829124
Fax 143303 0
Email 143303 0
Contact person for scientific queries
Name 143304 0
Sayaka Horiuchi
Address 143304 0
Burnet Institute 85 Commercial Rd, Melbourne VIC 3004
Country 143304 0
Australia
Phone 143304 0
+61421829124
Fax 143304 0
Email 143304 0

Data sharing statement
Will the study consider sharing individual participant data?
Yes
Will there be any conditions when requesting access to individual participant data?
Persons/groups eligible to request access:
Researchers
Conditions for requesting access:
Yes, conditions apply:
Requires review on a case-by-case basis by the trial custodian, sponsor or data sharing committee
Requires a scientifically sound proposal or protocol
Requires approval by an ethics committee
Requires a data sharing agreement between data requester and trial custodian or sponsor
What individual participant data might be shared?
All de-identified individual participant data
What types of analyses could be done with individual participant data?
Any type of analysis (i.e. no restrictions on data re-use)
When can requests for individual participant data be made (start and end dates)?
From:
After publication of main results
To:
No end date
Where can requests to access individual participant data be made, or data be obtained directly?
Email of trial custodian, sponsor or committee: [email protected]

Are there extra considerations when requesting access to individual participant data?
No


What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.